REPAIR Impact Fund

Executive Summary

The REPAIR Impact Fund, established by Novo Holdings in 2018, is dedicated to combating antimicrobial resistance by investing in companies focused on discovering and developing therapies targeting resistant microorganisms. Headquartered in Hellerup, Denmark, the fund aims to replenish the anti-infective pipeline globally.

Snapshot

Fund SizeN/A USD
Stages FocusSeries A
Sectors FocusPharmaceuticals, Medical Devices, Diagnostics, Bioinformatics, Biotechnology, Infectious Diseases, Health Technology, Therapeutics, Vaccines, Antimicrobial Resistance, Immunology, Microbiology, Genomics, Proteomics, Clinical Research
Portfolio Size3 companies

Investment Thesis

The REPAIR Impact Fund's investment thesis centers on supporting the discovery and early-stage development of innovative therapies aimed at resistant microorganisms. Key focus areas include novel antibiotics, antifungals, antivirals, and antiparasitics. The fund seeks to invest in companies with strong scientific foundations and the potential to bring groundbreaking solutions to market.

Team & Activity

Active team contains 4 members (1 partners, 0 founders).

Frequently Asked Questions